Article
PIK3CA Mutation Analysis in Iranian Patients with Gastric Cancer
Iranian biomedical journal - 1 Jan 2019
Iranpour Mostafa, Nourian Mahyar, Saffari Sana, Samizadeh Esmaeil, Mirghafori Mahdieh, Iravani Shahrokh, Ghafouri-Fard Soudeh
Abstract excerpt
Backgrounda: Aberrant activation of phosphatidylinositol-3 kinases (PI3K)/AKT/mTOR (mammalian target of rapamycin) pathway is a critical event during gastric cancer progression. Selective function of AKT inhibitor AZD5363 in PI3KCA mutant gastric cancer necessitates the assessment of PI3KCA mutations in these patients. Methods: The study included 100 patients with gastric cancer who underwent surgical resection...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
